ArticleFrontiers in oncology2025
Identification of endogenous reference genes for RT-qPCR analysis in breast cancer and matched adjacent tissues.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Real-time quantitative PCR (RT-qPCR), essential for gene expression and biomarker studies, requires stable endogenous reference genes (RGs) for normalization. This study aimed to identify consistently expressed RGs in breast cancer and adjacent tissues to facilitate comparative analyses of breast cancer-related gene expression. Material and methods: Five candidate RGs (β-actin, 18S rRNA, PUM1, RPLP0, TFRC) were analyzed by RT-qPCR from 30 breast cancer patients. Threshold cycle (Ct) values were evaluated using descriptive statistics, and stability of RGs was assessed using RefFinder, integrating GeNorm, NormFinder, ΔCt, and BestKeeper algorithms. Results: In cancer tissues, descriptive statistics showed that 18S rRNA was a suitable RG (Ct Range = 3.96; Mean Ct=8.43; SD = 0.84). RefFinder identified TFRC as the most stable RG (GM = 1.19), followed by 18S rRNA (GM = 1.41). In adjacent tissues, TFRC was find with its narrowest Ct range (Ct range = 6.29) and highest stability (GM = 1.00) by RefFinder. However, GeNorm and BestKeeper indicated instability for TFRC (M = 2.364, SD = 4.30), exceeding the stability threshold values of 1.5 and 1, respectively. Adjacent tissues displayed significantly higher Ct values than cancer tissues. TFRC may serve as the suitable RG for detecting gene expression when concerning both breast cancer and adjacent tissues (GM = 1.19), though, GeNorm and BestKeeper indicated its instability (M = 2.364, SD = 4.30). Conclusion: TFRC and 18S rRNA may be suitable RGs in breast cancer tissues, while all five candidates were not stable in adjacent tissues. Larger studies are needed to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.